Last reviewed · How we verify
anesthesics plus antiinflammatory, CLIFE1
CLIFE1 combines anesthetic and anti-inflammatory properties to provide pain relief and reduce inflammatory responses simultaneously.
CLIFE1 combines anesthetic and anti-inflammatory properties to provide pain relief and reduce inflammatory responses simultaneously. Used for Perioperative pain and inflammation management.
At a glance
| Generic name | anesthesics plus antiinflammatory, CLIFE1 |
|---|---|
| Also known as | lidocaine plus diclofenac, CLIFE1 topical gel |
| Sponsor | Hospital de Viladecans |
| Modality | Small molecule |
| Therapeutic area | Pain Management / Anesthesia |
| Phase | FDA-approved |
Mechanism of action
This combination drug is designed to deliver both local or general anesthetic effects to block pain sensation while concurrently suppressing inflammatory pathways. By addressing both pain and inflammation together, the formulation aims to improve patient comfort and reduce tissue damage associated with inflammatory conditions. The exact molecular targets and specific anesthetic/anti-inflammatory agents in CLIFE1 are not publicly detailed.
Approved indications
- Perioperative pain and inflammation management
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: